MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice
{{output}}
Background: Reducing serum low-density lipoprotein cholesterol (LDL-C) in hyperlipemia is recognized as an effective strategy to minimize the risk of atherosclerotic cardiovascular disease (ASCVD). MiR-337-3p has already been dis... ...
